As the state's only academic health center, OHSU's breakthrough research leads to new cures, new standards of care, and a better understanding of the basic science that drives biomedical discovery. OHSU researchers are exploring new basic, clinical, and applied research frontiers. Read about research at OHSU
Help drive new discoveries in radiation oncology with a donation to our labs.
The talents and resources of hundreds of individuals, institutions, and industries must be combined to achieve successful diagnosis and treatment of cancer and other diseases.
To help ensure success in the diagnosis and treatment of cancers and diseases, we have developed ongoing relationships with the following institutions:
- Department of Nuclear Engineering & Radiation Health Physics
- Transpire, Inc.
- Wacom Technology Corporation
This collaboration between institutions allows our team to be amongst the first to access any newly researched technologies.
This gives our team a unique opportunity to devise applications for improving the diagnosing of cancers and developing innovative therapeutic treatments. So when you enter our facilities, you can rest assured that the very best minds and machines are devoted to your care.
As part of a teaching institution, the Department of Radiation Medicine's faculty and staff will give presentations both within the department and around the world sharing their knowledge with others studying the field of medicine. Review the department's academic meetings presentations here
In the news: Radiation Medicine
July 27, 2022
Nima Nabavizadeh, M.D., associate professor and residency program director, is the new PI for the Pathfinder 2 study at OHSU.
Pathfinder 2 is OHSU's largest actively enrolling early cancer detection study using blood samples. The study is seeking volunteers 50 years and older without a known cancer diagnosis. OHSU also has other studies collecting samples from patients receiving routine lung screening with low-dose CT as well as those with a new cancer diagnosis but have yet to receive treatment.
April 29, 2022
Paige Arneson-Wissink, Ph.D. and Beth L. Worley, Ph.D., researchers in Grossberg Lab, presented at the American Association for Cancer Research (AACR) Annual Meeting 2022. Dr. Arneson-Wissink presented data on interleukin-6 derived from tumors impairs the liver’s response to undernutrition in pancreatic cancer cachexia and Dr. Worley detailed how blocking the RNA-binding protein called HuR might provide a new way treat cachexia caused by pancreatic cancer.
Read more here OHSU scientists represent at AACR
2022 Early Detection of Cancer Conference: October 18 - 20, 2022
Leaders in early detection and top scientists and innovators in cancer research and bioengineering will gather in Portland, Oregon, Oct. 18-20, 2022, for the seventh in the series organized by the OHSU Knight Cancer Institute and Cancer Research UK, joined in 2018 by the Canary Center at Stanford.
The Department of Radiation Medicine and the University of Washington's Department of Radiation Oncology are proud to host the Pacific Northwest Workshop on Methods in Radiation Oncology Clinical Trials. Details available here